Aachen, Germany, March 5, 2018 – Novartis Pharma AG was honored with a SAMS Award in the “Overall Project/Strategy” category at the SAM Strategies Conference in Berlin last week. Their “Top 100 Cost Reduction Initiative” project aimed to save significant money, gain software compliance transparency, and improve processes in software procurement and software usage.
“This project was very innovative, because we linked the procurement data with SAM information group-wide for the very first time. We achieved considerable savings by combining the capabilities of both departments and with the support of Aspera SmartTrack,” says the Project Manager Jutta Hangater, Global Head of IT Procurement Software at Novartis.
Jochen Hagenlocher, Global Head of SAM at Novartis confirms, “This Project has set new standards-not only for procurement but also for optimizing existing contracts. We were able to improve our SaaS contract conditions for example.”
“Congratulations to our customer Novartis for this well-deserved award. Their strategic project confirms the status of SAM and demonstrates innovative ways a SAM solution can be used and provide value for other enterprises,” states Olaf Diehl, Managing Director at Aspera.
At Aspera, we simplify the complexity of your software licenses. For nearly two decades, we have helped hundreds of enterprises and over 50 Fortune 500s to assess cost and risk within their IT environments. Our solutions for Software Asset Management track all the big vendors, such as IBM, Microsoft, Oracle and SAP to cover every environment from servers and desktops to cloud and mobile. With the largest in-house consultant and service team in the industry, we provide the best strategy for data discovery, easy system integration, and a cost-effective way to purchase, use and optimize licenses.
Aspera is part of USU Software AG (ISIN DE 000A0BVU28), which is listed in the Prime Standard segment of the Frankfurt Stock Exchange.
International Public Relations
Tel.: +49 241 963-3261
Fax: +49 241 963-1229
USU Software AG
Dr. Thomas Gerick
Tel.: +49 (0) 71 41 / 48 67-440
Fax: +49 (0) 71 41 / 48 67-108